Entera Bio Ltd. (ENTX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$11.53M | -20.3% |
| 2024 | -$9.59M | -7.8% |
| 2023 | -$8.89M | +31.7% |
| 2022 | -$13.02M | -6.5% |
| 2021 | -$12.22M | -9.4% |
| 2020 | -$11.17M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$11.53M | -20.3% |
| 2024 | -$9.59M | -7.8% |
| 2023 | -$8.89M | +31.7% |
| 2022 | -$13.02M | -6.5% |
| 2021 | -$12.22M | -9.4% |
| 2020 | -$11.17M | — |